Reaching Zero-Dose Children Webinar Series

September 8, 2022 - September 29, 2022

The Zero-Dose Children Webinar series will build understanding of how to reach key populations which are missed by immunisation and other basic health services including communities residing in poor urban areas (informal settlements), those affected by conflict and displacement and residents of remote-rural areas. A final webinar will unpack challenges in health workforce in reaching missed communities with basic health services. The webinars will share specific country experiences on the latest learning and best practices for bringing services to the hard-to-reach. This webinar series is a joint initiative between Technet, the Zero-Dose Community of Practice, and the Immunisation Agenda 2030 working group on coverage and equity.

  • Session 1: Urban immunisation
    08 Sep 2022 – 3pm CEST
  • Session 2: Immunization in fragile/conflict affected settings
    15 Sep 2022 – 3pm CEST
  • Session 3: Remote rural settings
    22 Sep 2022 – 3pm CEST
  • Session 4: Human resources for missed communities
    29 Sep 2022 – 3pm CEST

Register for one or more of the webinars here.

You May Also Like

VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

The Vaccine Procurement Practitioners Network (VPPN) will conclude their series on market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French. This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement … Read More

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More